The impact on Anti-Mullerian Hormone (AMH), uterine fibroid size and uterine artery patency following Uterine Fibroid Embolization (UFE) with a resorbable embolic agent.

Saved in:
Bibliographic Details
Title: The impact on Anti-Mullerian Hormone (AMH), uterine fibroid size and uterine artery patency following Uterine Fibroid Embolization (UFE) with a resorbable embolic agent.
Authors: Hacking N; Department of Interventional Radiology, University Hospital Southampton, Southampton, UK., Vigneswaran G; Department of Interventional Radiology, University Hospital Southampton, Southampton, UK.; Cancer Sciences, University of Southampton, Southampton General Hospital, Tremona Road, Southampton, UK., Maclean D; Department of Interventional Radiology, University Hospital Southampton, Southampton, UK., Bryant T; Department of Interventional Radiology, University Hospital Southampton, Southampton, UK., Umranikar S; Department of Obstetrics and Gynaecology, University Hospital Southampton, Southampton, UK., Cheong Y; Human Development and Health Faculty of Medicine, University of Southampton, Southampton, UK.; Complete Fertility Southampton, Princess Anne Hospital, Southampton, UK., Modi S; Department of Interventional Radiology, University Hospital Southampton, Southampton, UK.
Source: Human fertility (Cambridge, England) [Hum Fertil (Camb)] 2022 Dec; Vol. 25 (5), pp. 881-887. Date of Electronic Publication: 2021 Apr 30.
Publication Type: Journal Article
Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 100888143 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1742-8149 (Electronic) Linking ISSN: 14647273 NLM ISO Abbreviation: Hum Fertil (Camb) Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1742-8149
DOI:10.1080/14647273.2021.1920055